IV PERSANTINE Drug Patent Profile
✉ Email this page to a colleague
When do Iv Persantine patents expire, and when can generic versions of Iv Persantine launch?
Iv Persantine is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in IV PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iv Persantine
A generic version of IV PERSANTINE was approved as dipyridamole by BARR on October 3rd, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IV PERSANTINE?
- What are the global sales for IV PERSANTINE?
- What is Average Wholesale Price for IV PERSANTINE?
Summary for IV PERSANTINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 148 |
Clinical Trials: | 9 |
Patent Applications: | 4,019 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IV PERSANTINE at DailyMed |
![IV PERSANTINE drug patent expirations Drug patent expirations by year for IV PERSANTINE](/p/graph/s/t/IV_PERSANTINE-patent-expirations.png)
Recent Clinical Trials for IV PERSANTINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guo-Qing Jiang | N/A |
Shanghai Children's Hospital | Phase 1/Phase 2 |
Chengdu University of Traditional Chinese Medicine | Phase 1/Phase 2 |
US Patents and Regulatory Information for IV PERSANTINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | IV PERSANTINE | dipyridamole | INJECTABLE;INJECTION | 019817-001 | Dec 13, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |